Phase 3 Readout
FOLD: Phase 3 Topline: An Open-label Study to Evaluate the Safety and Pharmacokinetics of Migalastat HCl in Subjects With F
December 31, 2026. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- December 31, 2026
- Company
- AMICUS THERAPEUTICS, INC. (FOLD)
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 3 Readout~month
Phase 3 Topline: An Open-label Study to Evaluate the Safety and Pharmacokinetics of Migalastat HCl in Subjects With F
- Indication
- Fabry Disease